Brief: Ocean Biomedical (Nasdaq Ocea) Announces New Patent For Anti-Fibrosis Discovery
29/08/2023 13:39
Aug 29 (Reuters) - Ocean Biomedical Inc OCEA.O :
* OCEAN BIOMEDICAL (NASDAQ: OCEA) ANNOUNCES NEW PATENT FOR
ANTI-FIBROSIS DISCOVERY WITH ALLOWANCE IN ALCOHOLIC LIVER
DISEASE AND MULTIPLE FIBROTIC CONDITIONS, LEADING CAUSES OF
DEATH IN THE U.S.
Source text for Eikon: ID:nGNX9V8WbF
Further company coverage: OCEA.O
Recent news on Ocean Biomedical
See all newsTrump's shipbuilding plan could upend ocean cargo industry, companies warn
Brief: Ocean Biomedical Announces Breakthrough Findings In EGFR-Mutant Lung Cancer
Brief: Ocean Biomedical Announces Receipt Of Notice From Nasdaq Regarding Late Filing Of Quarterly Report On Form 10-Q
Brief: Ocean Biomedical receives Nasdaq staff determination letter
Brief: Ocean Biomedical- Ratified Fully Countersigned Copy Of Revised Agreement With Virion Therapeutics Received On Sept 26